Add Company
Join Now

Imvaq Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Imvaq Therapeutics's estimated annual revenue is currently $310k per year.(i)
  • Imvaq Therapeutics's estimated revenue per employee is $77,500

Employee Data

  • Imvaq Therapeutics has 4 Employees.(i)
  • Imvaq Therapeutics grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

Imvaq is an innovative biotechnology company developing novel immuno-oncologics to treat metastatic cancer. Based on the research of Imvaq's distinguished scientific founders at Memorial Sloan Kettering Cancer Center, one of the leading clinical and R&D cancer hospitals in the world, we are focused on creating therapeutic products that synergize with a patient's own immune system to eradicate the cancer, locally and abscopally.

keywords:N/A

N/A

Total Funding

4

Number of Employees

$310k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Imvaq Therapeutics's People

NameTitleEmail/Phone
1
VP, ManufacturingReveal Email/Phone
Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M4-33%N/A
#2
$0.3M4-20%N/A
#3
$0.5M40%N/A
#4
$0.3M40%N/A
#5
$0.3M4-33%N/A